Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Employment agrmnt
CC transcript
Appointed CFO
Quarterly results
Director comp.
Director departure
Appointed director
MICROMET, INC. (MITI) Create: Alert

All | News | Filings
Date FiledTypeDescription
03/07/2012 8-K Quarterly results
01/27/2012 8-K Amended existing or entered into new employment agreement with an officer, Appointed a new director
Docs: "Agreement and Plan of Merger, by and among Micromet, Inc., Amgen Inc. and Armstrong Acquisition Corp",
"Form of Tender and Support Agreement, by and among Amgen Inc., Armstrong Acquisition Corp. and certain stockholders of Micromet, Inc",
"Second Amendment to Rights Agreement, by and between Micromet, Inc. and American Stock Transfer & Trust Company, LLC",
"Amendment to Executive Employment Agreement, by and among Micromet, Inc., Amgen Inc. and Dr. Jan Fagerberg",
"Amendment to Executive Employment Agreement, by and among Micromet, Inc., Amgen Inc. and Prof. Dr. Patrick A. Baeuerle"
11/08/2011 8-K Form 8-K - Current report
08/04/2011 8-K Form 8-K - Current report
07/28/2011 8-K/A Submission of Matters to a Vote of Security Holders
07/15/2011 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Docs: "Micromet Announces Solid Tumor BiTE Antibody Collaboration with Amgen - Collaboration on up to three targets and two programs - Upfront payment of €10 million upon deal execution - Maximum deal value of €695 million plus royalties and development cost reimbursement"
06/28/2011 8-K Form 8-K - Current report
05/10/2011 8-K Quarterly results
Docs: "Micromet Reports First Quarter 2011 Financial Results and Highlights Near-Term Milestones -Data from Phase 2 clinical trial of blinatumomab in patients with relapsed/refractory ALL accepted for presentation at EHA Annual Congress in June -Hagop Kantarjian, M.D., Chairman and Professor, Department of Leukemia, MD Anderson to participate in conference call scheduled for today at 8:30 AM ET"
04/04/2011 8-K Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review, Departure of Di...
03/03/2011 8-K Form 8-K - Current report
03/01/2011 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
11/12/2010 8-K Form 8-K - Current report
11/09/2010 8-K Form 8-K - Current report
10/22/2010 8-K Form 8-K - Current report
08/05/2010 8-K Form 8-K - Current report
06/25/2010 8-K Submission of Matters to a Vote of Security Holders
05/10/2010 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Docs: "Boehringer Ingelheim and Micromet Announce Global Collaboration for Multiple Myeloma BiTE Antibody"
05/05/2010 8-K Quarterly results
Docs: "Micromet Reports First Quarter 2010 Financial Results"
04/16/2010 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Micromet Announces Resignation from its Board of Directors"
03/29/2010 8-K Form 8-K - Current report
03/12/2010 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Docs: "Underwriting Agreement, by and between Micromet and Goldman, Sachs & Co., as representative for the underwriters named therein",
"Opinion of Cooley Godward Kronish LLP",
"Micromet Announces Pricing of Public Offering of 10 Million Shares of Common Stock"
03/09/2010 8-K Other Events, Financial Statements and Exhibits
Docs: "Achieve a specified goal in one of the Company’s product development collaborations"
03/04/2010 8-K Quarterly results
Docs: "Micromet Reports Fourth Quarter and Full Year 2009 Financial Results"
02/05/2010 8-K Form 8-K - Current report
11/27/2009 8-K Form 8-K - Current report
11/05/2009 8-K Quarterly results
Docs: "Micromet, Inc. Reports Third Quarter 2009 Financial Results"
11/05/2009 8-K Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Other Events, Financial Statement...
Docs: "Micromet Buys Out MedImmune’s Remaining Rights to Blinatumomab"
11/03/2009 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Docs: "Micromet and Sanofi-aventis Sign Global Collaboration and License Agreement for New Solid Tumor BiTE Antibody"
08/06/2009 8-K Form 8-K - Current report
07/30/2009 8-K Entry into a Material Definitive Agreement, Results of Operations and Financial Condition, Other Events, Financial Statements...
Docs: "Purchase Agreement, by and between Micromet and Piper Jaffray & Co., as representative for the underwriters named therein",
"Opinion of Cooley Godward Kronish LLP",
"Micromet Announces Pricing of Public Offering of Common Stock"
07/10/2009 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
05/06/2009 8-K Form 8-K -- Current report
03/12/2009 8-K Form 8-K -- Current report
02/23/2009 8-K Form 8-K -- Current report
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy